Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases

Genomics. 2017 Oct;109(5-6):391-400. doi: 10.1016/j.ygeno.2017.06.004. Epub 2017 Jun 23.

Abstract

Among Down syndrome (DS) children, 40-50% have congenital heart disease (CHD). Although trisomy 21 is not sufficient to cause CHD, three copies of at least part of chromosome 21 (Hsa21) increases the risk for CHD. In order to establish a genotype-phenotype correlation for CHD in DS, we built an integrated Hsa21 map of all described partial trisomy 21 (PT21) cases with sufficient indications regarding presence or absence of CHD (n=107), focusing on DS PT21 cases. We suggest a DS CHD candidate region on 21q22.2 (0.96Mb), being shared by most PT21 cases with CHD and containing three known protein-coding genes (DSCAM, BACE2, PLAC4) and four known non-coding RNAs (DSCAM-AS1, DSCAM-IT1, LINC00323, MIR3197). The characterization of a DS CHD candidate region provides a useful approach to identify specific genes contributing to the pathology and to orient further investigations and possibly more effective therapy in relation to the multifactorial pathogenesis of CHD.

Keywords: Congenital heart disease; Down syndrome; Human chromosome 21; Partial trisomy 21.

MeSH terms

  • Amyloid Precursor Protein Secretases / genetics
  • Aspartic Acid Endopeptidases / genetics
  • Cell Adhesion Molecules / genetics
  • Chromosome Mapping / methods*
  • Chromosomes, Human, Pair 21 / genetics*
  • Down Syndrome / complications*
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Heart Defects, Congenital / genetics*
  • Humans
  • Pregnancy Proteins / genetics
  • RNA, Long Noncoding / genetics

Substances

  • Cell Adhesion Molecules
  • DSCAM protein, human
  • PLAC4 protein, human
  • Pregnancy Proteins
  • RNA, Long Noncoding
  • Amyloid Precursor Protein Secretases
  • Aspartic Acid Endopeptidases
  • BACE2 protein, human